Kezar Life Sciences Inc Live Stock Price Today, Share Analysis and Chart

Name: Kezar Life Sciences Inc: Is Infosys Ltd. worth buying?
Item: Kezar Life Sciences Inc
Rating: 1.87425
Author: Trendlyne DVM scores

about

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetom...

6.34 0.02 (0.32%)

79.60% Gain from 52W Low

67,905

XNAS Volume

XNAS 19 Dec, 2025 4:30 PM (EST)

Not Eligible

Expensive Valuation

15.0 / 100

Technically Moderately Bullish

60.0 / 100

1Yr Price target upside is 97%

2 analysts

Kezar Life Sciences Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Kezar Life Sciences Inc Live Stock Price Today, Share Analysis and Chart

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetom...

79.60% Gain from 52W Low

SWOT Analysis

Kezar Life Sciences Inc Live Price Chart